Harvest Management’s Aerie Pharmaceuticals AERI Stock Holding History

Harvest Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$757K	–	67
2022 Q3	$757K	Buy	+50,000	New	+$581K	0.61%	33

Harvest Management's AERI Position: Q4 2022 in Review

Harvest Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 50,000 shares — an estimated $757K sold.

Harvest Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $757K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Harvest Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Harvest Management sold 50,000 Aerie Pharmaceuticals shares in Q4 2022, an estimated $757K.
Harvest Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Harvest Management's Aerie Pharmaceuticals position peaked at $757K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Harvest Management's 13F filing for Q4 2022, filed 14 Feb 2023.